Diagnosis and Management of Wide QRS Complex Tachycardia

Introduction to Wide QRS Complex Tachycardia

When encountering a broad QRS complex tachycardia (>120 ms), always assume it is ventricular tachycardia (VT) until proven otherwise, as misdiagnosis and inappropriate treatment can lead to significant morbidity and mortality, according to the American College of Cardiology 1

A history of myocardial infarction or structural heart disease strongly suggests VT, as stated by the American College of Cardiology 1
The first occurrence of wide QRS tachycardia after infarction is highly indicative of VT, as noted by the American College of Cardiology 1
Morphological criteria are less reliable in patients taking certain antiarrhythmic drugs, those with hyperkalemia, or severe heart failure, according to the American College of Cardiology 1

Diagnostic criteria for VT include:

Diagnostic Criterion	Description
AV Dissociation	Ventricular rate faster than atrial rate (visible in only 30% of VTs)
Fusion Complexes	Pathognomonic for VT
QRS Width	>140 ms with RBBB pattern or >160 ms with LBBB pattern
Concordance	All precordial leads show either positive or negative deflections

Initial R wave, initial R or Q wave >40 ms, and notch on descending limb of predominantly negative QRS suggest VT 1
R-wave peak time ≥50 ms in lead II suggests VT 3
Recording a 12-lead ECG during maneuvers can help differentiate between SVT and VT, as SVT often terminates or shows transient AV block revealing atrial activity, while VT typically remains unaffected 1
Vagal maneuvers may help differentiate between AVNRT/AVRT, preexcited AF, and atrial tachycardia, as AVNRT/AVRT often terminate with vagal maneuvers, while preexcited AF shows transient slowing of ventricular rate but typically doesn't terminate 3
Response to adenosine, such as termination or transient AV block revealing atrial activity, can help differentiate between VT and SVT 2, 3

If diagnosis remains uncertain after evaluation, treat as VT, as recommended by the American College of Cardiology 1
Avoid calcium channel blockers in undiagnosed wide QRS tachycardias as they may cause hemodynamic collapse in VT, according to the American College of Cardiology 1
The American College of Cardiology recommends differentiating between Supraventricular Tachycardia (SVT) and Ventricular Tachycardia (VT) through QRS complex width, with VT typically presenting with QRS >120 ms, while SVT usually has narrow QRS <120 ms, though when in doubt, wide complex tachycardia should be treated as VT until proven otherwise 1, 3
Asymptomatic self-limiting supraventricular tachycardia episodes do not require specific therapy or further diagnostic evaluation, as long as there is no underlying structural heart disease or other risk factors, as recommended by the American College of Cardiology 2
Identifying and eliminating triggering factors, such as excessive caffeine, alcohol, or nicotine consumption, recreational drugs, and hyperthyroidism, is suggested by the American College of Cardiology 2
Caution is recommended when using antiarrhythmic drugs, due to the risk of proarrhythmia, and class I or III antiarrhythmic drugs should not be initiated without documented arrhythmia, as recommended by the American College of Cardiology 2
If hemodynamically unstable, immediate DC cardioversion is recommended regardless of diagnosis, following guidelines from the American Heart Association 2

A 12-lead ECG during tachycardia should be obtained to characterize the arrhythmia and determine QRS width, with narrow QRS suggesting supraventricular tachycardia and wide QRS requiring differentiation between SVT with aberrancy and ventricular tachycardia, as recommended by the American College of Cardiology 1, 4
Transthoracic echocardiography should be performed to assess ventricular function, wall motion abnormalities, pericardial effusion, and valvular abnormalities 5
Cardiac MRI with gadolinium enhancement can help evaluate for myocardial inflammation, scarring, and regional wall motion abnormalities 6
Complete blood count, comprehensive metabolic panel, cardiac biomarkers, inflammatory markers, and angiotensin-converting enzyme level should be obtained, with consideration of specific tests based on clinical suspicion, such as tuberculosis or Lyme disease testing 7

An electrophysiological study is not indicated in asymptomatic patients with self-limiting tachycardia or in patients with well-controlled tachycardia through vagal maneuvers or well-tolerated medications, as suggested by the American College of Cardiology 8
Further electrophysiological evaluation with the option of catheter ablation should be considered in patients with recurrent, symptomatic episodes that do not respond to conservative measures, as recommended by the American College of Cardiology 8
Electrophysiologic study with electroanatomical mapping may be useful in patients with recurrent ventricular tachycardia to identify low-voltage areas corresponding to scarring and guide catheter ablation 6